Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 10/20 | 0.60 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.44 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.43 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18172171 | 0.83 | SCN9A (0.78) | SCN9ASCN5AMAPTNPC1RAB9A | |
| SCHEMBL18172215 | 0.75 | SCN9A (1.00) | SCN9AMAPK14SCN5AMAPTNPC1 | |
| SCHEMBL18172201 | 0.74 | SCN9A (0.72) | SCN9AMAPK14SCN5AMALT1LCK | |
| SCHEMBL18172174 | 0.72 | SCN9A (0.75) | SCN9AMAPK14HCRTR1SCN5AMAPT | |
| SCHEMBL18172119 | 0.71 | SCN9A (1.00) | SCN9ASCN5ANPC1RAB9A | |
| SCHEMBL1691798 | 0.71 | RIPK2 (0.61) | SCN9AMAPK14SCN5ANPC1RAB9A | |
| SCHEMBL18172107 | 0.71 | SCN9A (0.80) | SCN9AHCRTR1SCN5ANPC1RAB9A | |
| SCHEMBL18172179 | 0.71 | SCN9A (0.62) | SCN9AMAPK14SCN5AMAPTNPC1 | |
| SCHEMBL18172216 | 0.70 | SCN9A (0.72) | SCN9AMAPK14SCN5AMAPTNPC1 | |
| SCHEMBL18172191 | 0.70 | SCN9A (0.75) | SCN9AHCRTR1SCN5AMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3286178-A1 | AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS | Almirall S.A. (ES) | 2018-02-28 | — | — | EP | disclosed |
| WO-2016170009-A1 | AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS | ALMIRALL, S.A. (ES) | 2016-10-27 | — | — | WO | disclosed |